Dr. Derek A Besing, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 328 N 2nd St Ste 205, Vincennes, IN 47591 Phone: 812-882-3312 Fax: 812-882-6181 |
David P Grundman Dpm Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 902 N 7th Street, Vincennes, IN 47591 Phone: 812-882-3312 Fax: 812-882-6181 |
Dr. Austin Roy Muranaka, D.P.M. Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 202 Broadway St, Vincennes, IN 47591 Phone: 812-882-3312 Fax: 812-882-6181 |
Dr. David Paul Grundman, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 902 N 7th Street, Vincennes, IN 47591 Phone: 812-882-3312 Fax: 812-882-6181 |
Vincennes Podiatry Associates, Llc Podiatrist - Foot & Ankle Surgery Medicare: Not Enrolled in Medicare Practice Location: 202 Broadway St, Vincennes, IN 47591 Phone: 812-882-3312 Fax: 812-882-6181 |
News Archive
Boston Scientific Corporation (NYSE: BSX) today announced the completion of patient enrollment in the workhorse portion of its PLATINUM clinical program. PLATINUM is a global, randomized, pivotal controlled trial designed to support U.S. Food and Drug Administration (FDA) and Japanese Ministry of Health, Labor and Welfare (MHLW) approval of the platinum chromium PROMUS((R)) Element(TM) Everolimus-Eluting Coronary Stent System.
Nanion Technologies, a leading provider of automated patch clamp platforms, and Axion Biosystems, originator of the first high throughput microelectrode array system, today announce a distribution partnership in Europe and China. Nanion will immediately carry Axion's MEA-products, supporting a broad range of biomedical applications.
Insurance companies should disclose more information about how they spend money to justify their rate hikes, Health and Human Services Secretary Kathleen Sebelius told a group of insurance executives during a White House meeting Thursday, the San Francisco Chronicle reports.
GenVec, Inc., PATH's Malaria Vaccine Initiative (MVI), and the U.S. Naval Medical Research Center (NMRC) today announced a dynamic partnership to assess whether five malaria antigens, or proteins, can generate strong immune responses alone or in combination. This partnership will advance and expand the ongoing malaria vaccine development program between GenVec and NMRC. Malaria is one of the world's three leading infectious disease killers.
› Verified 2 days ago